Changes associated
with age in immune function in experimental animals and in humans have been described1.
It is well established that lymphocytes from subjects over 65 years of age, incorporate less thymidine than those from young subjects when cultured with plant lectin2^.
Recent studies revealed that mitogen-induced proliferation of murine and human T lymphocytes in culture is driven by IL-2, T cell growth factor, produced by T lymphocytes being stimulated with lectins or antigen. Some authors3'4' suggested that the proliferation of lymphocytes may depend upon their capacities to produce IL-2 and their abilities to respond to IL-2. It was reported that in vitro incubation of human lymphocytes with IL-2 can induce the proliferation to their CLC-IL-2 and CLC-IL-2 thus derived were reported to exhibit a strong cytotoxic reactivity against the tumor cells resistant to lysis of natural killer cells and also against NK-sensitive tumor cells ' 5 .
Little is known for the proliferative ability of aged PBL in the presence of exogenous IL-2 and the cytotoxic reactivities of CLC-IL-2 derived from aged PBL. In the present study, PBL from the young and aged subjects were found to be able to propagate to a large number with IL-2 and CLC-IL-2 thus derived from aged PBL exhibit a strong cytotoxic reactivity against the NKsensitive target cell K562 like young PBL, were reported.
MATERIALS AND METHODS

Subjects
Blood was obtained from healthy persons between 21 and 31 years in our laboratory and from those volunteers of ages ranging from 71 to 90 years old. Care was taken to choose the aged persons who were found to be healthy or apparently healthy without those diseases enough NK-sensitive target cell K562. The cytotoxic reactivity of fresh PBL in the aged group was 30.5 ± 7.7%, which did not differ from that in the young group (29 ± 9.8%).
CLC-IL-2 derived from the aged and the young groups showed strong cytotoxic reactivity (75.9 ± 3.5 and 77.3 ± 3.2%, respectively).
No significant difference was found between both groups (Table 4) . 
